Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir in HIV-1 Infected Children and Adolescents
NCT00485264Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2007
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of raltegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2007; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00485264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00485264.